NLRP3 and metabolic syndrome: Recent evidence shows mechanistic roles of new biomarkers including a multiprotein complex called nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome in the pathogenesis of metabolic syndrome (49).